AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,267,951 | -19.4% | 80,083 | -34.6% | 0.01% | -26.7% |
| Q1 2023 | $2,814,606 | -34.1% | 122,534 | -19.5% | 0.02% | -40.0% |
| Q4 2022 | $4,272,147 | -21.9% | 152,142 | -21.4% | 0.02% | -30.6% |
| Q3 2022 | $5,471,000 | +74.2% | 193,475 | +36.6% | 0.04% | +89.5% |
| Q2 2022 | $3,140,000 | -0.9% | 141,655 | +30.1% | 0.02% | +18.8% |
| Q1 2022 | $3,170,000 | +12.8% | 108,888 | +27.4% | 0.02% | +14.3% |
| Q4 2021 | $2,810,000 | -41.5% | 85,478 | -17.9% | 0.01% | -44.0% |
| Q3 2021 | $4,805,000 | +233.0% | 104,123 | +297.7% | 0.02% | +257.1% |
| Q2 2021 | $1,443,000 | +226.5% | 26,180 | +205.7% | 0.01% | +250.0% |
| Q1 2021 | $442,000 | – | 8,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |